Skip navigation

Advance Patient Services, Enhance Program Effectiveness and Drive Speed to Therapy

September 12-13, 2018
  • San Diego, CA

With increased demand for affordable, value-based treatment options, bio/pharmaceutical teams face an intensely competitive market, for both specialty and non-specialty products. The escalating challenges associated with product and patient services require novel, innovative strategies for customizing products and services designed to meet patient needs. CBI’s 11th Hub and SPP Model Optimization provides executives with strategies for developing and integrating hub programs and other patient-centric services to ensure product access and maximize reimbursement.

DELIVERING COMPELLING CONTENT
AND KEY INSIGHTS:

  • Discuss patient services hub design for cell and gene therapies
  • Review the overall end-to-end experience from the physician
    and patient perspective in e-prescribing, prior authorization
    and dispensing workflows
  • Discuss the impact of DIR Fees on practice based pharmacies
  • Examine best practices on the development and administration
    of a third-party monitoring and oversight program
  • Understand the consequences of narrow channel medication
    distribution on patient adherence in post-acute care
  • Gain an understanding for how to consolidate
    specialty distribution data
  • Use EHR technologies to determine formulary, launch
    electronic prior authorizations and streamline fills at
    retail pharmacies and through mail-away hubs

11th Hub and SPP Model Optimization

Advance Patient Services, Enhance Program Effectiveness and Drive Speed to Therapy

With increased demand for affordable, value-based treatment options, bio/pharmaceutical teams face an intensely competitive market, for both specialty and non-specialty products. The escalating challenges associated with product and patient services require novel, innovative strategies for customizing products and services designed to meet patient needs. CBI’s 11th Hub and SPP Model Optimization provides executives with strategies for developing and integrating hub programs and other patient-centric services to ensure product access and maximize reimbursement.

DELIVERING COMPELLING CONTENT
AND KEY INSIGHTS:

  • Discuss patient services hub design for cell and gene therapies
  • Review the overall end-to-end experience from the physician
    and patient perspective in e-prescribing, prior authorization
    and dispensing workflows
  • Discuss the impact of DIR Fees on practice based pharmacies
  • Examine best practices on the development and administration
    of a third-party monitoring and oversight program
  • Understand the consequences of narrow channel medication
    distribution on patient adherence in post-acute care
  • Gain an understanding for how to consolidate
    specialty distribution data
  • Use EHR technologies to determine formulary, launch
    electronic prior authorizations and streamline fills at
    retail pharmacies and through mail-away hubs